Cantor Fitzgerald Weighs in on NBIX FY2026 Earnings
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Neurocrine Biosciences in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer expects that the company will earn $6.53 per share for the year. The consensus […]
